Learn More
Gibco™ Rat CXCL2 (GRO beta) Recombinant Protein, PeproTech®
Recombinant Protein
Marca: Gibco™ 400-11-1MG
Descripción
Recombinant Rat GRO-beta/MIP-2 is a 7.9 kDa protein consisting of 73 amino acids, including the 'ELR' motif common to the CXC chemokine family that binds to CXCR1 or CXCR2. This product is shipped at ambient temperature. For storage, handling and reconstitution information, please see the lot-specific Certificate of Analysis
Produced by activated monocytes and neutrophils and expressed at sites of inflammation. Hematoregulatory chemokine, which, in vitro, suppresses hematopoietic progenitor cell proliferation. GRO-beta(5-73) shows a highly enhanced hematopoietic activity.
Especificaciones
P30348 | |
protein with no preservative | |
7.9 kDa | |
1 mg | |
RUO | |
C Cmotif chemokine; C x C motif chemokine; CC motif chemokine; CCmotif chemokine; chemokine (C-X-C motif) ligand 2; CINC-2 A; Cinc3; CINC-3; CXC; CXC motif chemokine; C-X-C motif chemokine 2; C-X-C motif chemokine ligand 2; CXCL; CXCL2; Cytokine-induced neutrophil chemoattractant 3; GRO b; gro beta; GRO β; GRO2; GRO2 oncogene; GROb; GRObeta; gro-beta; GRO-beta(5-73); GRO-beta-T; Growth-regulated protein beta; GROβ; Hematopoietic synergistic factor; HSF; Macrophage inflammatory protein 2; macrophage inflammatory protein 2-alpha; melanoma growth stimulatory activity beta; MGSA beta; Mgsa-b; MIP 2 A; MIP 2 alpha; MIP 2 A; Mip2; MIP-2; MIP2 a; MIP2 a; MIP2A; MIP-2 A; MIP2-alpha; SB-251353; Scyb; Scyb2; small inducible cytokine subfamily, member 2 | |
Cxcl2 | |
Unconjugated | |
VVVASELRCQ CLTTLPRVDF KNIQSLTVTP PGPHCAQTEV IATLKDGHEV CLNPEAPLVQ RIVQKILNKG KAN | |
E. coli | |
≥ 98% by SDS-PAGE gel and HPLC analyses. |
ELISA, Functional Assay, Western Blot | |
114105 | |
Rat CXCL2 (GRO beta) | |
E. coli | |
<1 EU/ μg | |
CXCL2 | |
Determined by its ability to chemoattract rat neutrophils using a concentration range of 10.0-100.0 ng/ml | |
Recombinant | |
-20°C | |
Lyophilized |
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.